Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Compliance and regulatory

China Enforces Interim Registration on 40 AI, Solar and Biotech Export-Control Technologies

China enforces interim pre-export registration on 40 emerging AI, photovoltaic, and biotech technologies following the close of public consultation.

Published 21 Nov 2026· 8 minute read
Rows of enterprise data center server racks housing computing infrastructure
Photo: Carl Lender from Sunrise, USA / Wikimedia Commons, CC BY 2.0 (cropped). Source · Licence

Following the November 15, 2026 close of public consultation on Announcement [2026] No. 48, China’s Ministry of Commerce and Ministry of Science and Technology are enforcing immediate interim pre-export registration across 40 technologies proposed for addition to the national export-control catalogue, compelling international research universities, cross-border joint institutes, and technology-transfer offices to audit outbound data transfers and collaborative intellectual property arrangements.

Scope of the 40 Controlled Technologies

The regulatory transition, initiated formally on November 16, 2026, marks the operational shift from public notice to active administrative gatekeeping. Jointly promulgated by China’s Ministry of Commerce (MOFCOM) Bureau of Industry Security and Export Control and the Ministry of Science and Technology (MOST) under Article 20 of the Foreign Trade Law and the Regulations on Technology Import and Export Administration, the initiative updates the Catalogue of Technologies Prohibited or Restricted from Export. While formal Catalogue additions were open for public comment through mid-November, Chinese trade authorities enacted a mandatory pre-export filing obligation that took immediate effect upon publication.

The 40 targeted technologies expand oversight across three strategic domains. Regulators divided the technologies into two legal tiers: 14 technologies are prohibited from export, imposing an absolute ban on cross-border transfer, while 26 technologies are restricted from export, requiring administrative licensing reviews.

Artificial intelligence accounts for 23 of the 40 items, targeting foundation model parameters, large language model weights, autonomous agent architectures, intelligent computing clusters, and automated vulnerability discovery tools. The remaining items cover 12 photovoltaic manufacturing technologies—focusing on polysilicon crystallization, wafer slicing, and high-efficiency solar cells—and 5 biomanufacturing technologies encompassing cell and gene therapies, small nucleic acid platforms, and pathogen genetic modification methods.

Technical Thresholds, Prohibitions, and Sourced Specifications

The regulatory schedule establishes concrete technical thresholds to distinguish between prohibited systems, restricted technologies subject to licensing, and unencumbered commercial activities.

Technology Sector Proposed Items Prohibited Scope Restricted Scope and Thresholds Primary Regulatory Pathway
Artificial Intelligence 23 technologies Models trained on state “core data”; offensive cyber tools; defense or critical infrastructure agents Models with compute ≥10²⁶ FLOPs, ≥2 trillion parameters, or top-10 benchmark ranking; clusters ≥10,000 GPUs Licensing review with open-source/academic exclusions and automated cloud filing
Photovoltaics (Solar) 12 technologies Monocrystalline ingot casting and proprietary wafer slicing processes Perovskite/tandem module fabrication; heterojunction cells; polysilicon lines ≥30,000 tons/year Licensing review explicitly extended to physical manufacturing equipment and process tooling
Biomanufacturing 5 technologies Genetic modification of specified pathogens; outbound transfers of platform IP ownership Platforms discovering undisclosed novel biological targets; commercial cell/gene therapy processes Product-specific licensing carve-outs with automatic licensing for non-ownership deals

For large language models, restricted status applies when a model satisfies any of three quantitative tests: training compute reaching or exceeding 10²⁶ floating-point operations (FLOPs), total model parameters reaching or exceeding 2 trillion, or global top-10 performance on recognized public benchmarks. When a model crosses these thresholds, restrictions attach to model weights, training checkpoints, architecture design documents, and optimization know-how.

Crucially, the rules establish explicit carve-outs. Technologies that have entered the public domain through open-source repository releases or published peer-reviewed academic literature are expressly excluded. Furthermore, MOFCOM clarified that providing foreign end-users with remote access to models hosted on domestic Chinese servers via Application Programming Interfaces (APIs), Software-as-a-Service (SaaS) portals, mobile applications, or lightweight on-device runtimes does not constitute a technology export. An export occurs only when model weights, code, or custodial infrastructure are physically transferred or deployed on foreign infrastructure.

In biomanufacturing, authorities introduced a distinction between platform ownership and product-specific licensing. The export prohibition applies exclusively to outbound assignments of intellectual property ownership over reusable foundational platforms. Cross-border out-licensing agreements involving specific therapeutic drug candidates remain eligible for streamlined administrative reviews and prospective automatic licensing, provided that underlying platform intellectual property remains domiciled in China.

Evolution of China’s Technology Export Control Regime

The enforcement of Announcement [2026] No. 48 represents the most substantial structural revision to China’s technology export controls since August 2020. China maintains two parallel statutory frameworks governing cross-border transfers. The dual-use export control regime, administered under the Export Control Law of 2020, governs tangible items, software, and technical data with dual civilian and military utility. In contrast, the technology-trade regime, established under the Foreign Trade Law and the Regulations on Technology Import and Export Administration, regulates commercial transfers of intellectual property, proprietary know-how, and industrial contracts.

The Catalogue was established in 2001 and revised in 2008 and 2020. The 2020 amendments added personalized recommendation algorithms and speech synthesis. The 2026 revisions expand this conceptual foundation to foundational compute infrastructure, synthetic biology platforms, and renewable energy manufacturing.

International regulatory divergence forms the broader context for these measures. As Western jurisdictions expand export controls through instruments such as the United States Export Control Reform Act, semiconductor equipment restrictions, and outbound investment screening, Chinese authorities have modernized their legal architecture. The November 2026 interim measures establish a statutory perimeter designed to prevent the unauthorized transfer of critical technological capabilities developed with domestic funding or proprietary subsidies.

International trade counsel and industry research bodies have evaluated institutional exposure under the interim rules. Legal practitioners at Baker McKenzie observed that immediate interim registration creates an enforceable compliance obligation before the final Catalogue is codified into law. Trade attorneys noted that while registration does not constitute formal export approval, failure to complete pre-export filings before transferring controlled code, data, or technical assistance exposes institutions to administrative penalties under Chinese foreign trade law.

Technical governance analysts at the Cloud Security Alliance highlighted the sophistication of the quantitative criteria, noting that compute thresholds at 10²⁶ FLOPs align with international safety evaluation benchmarks. The organization stressed that separating API-based service access from localized model weight deployments offers vital operational clarity, allowing multinational software ecosystems to operate across Chinese borders so long as model custody remains inside domestic server facilities.

In life sciences, legal specialists at Morgan Lewis emphasized that multinational pharmaceutical developers must conduct immediate portfolio reviews. Corporate acquirers and licensees were advised to structure licensing transactions as product-specific grants rather than platform acquisitions, ensuring that deal documents explicitly separate specific drug candidates from reusable screening platforms to avoid triggering mandatory export prohibitions.

Cross-border investment advisors at Pillsbury Winthrop Shaw Pittman warned that interim registration reaches beyond conventional technology sales. The firm highlighted that corporate mergers, equity acquisitions, or corporate restructuring transactions that result in a foreign entity acquiring actual control over a domestic Chinese entity holding controlled technologies constitute an export event requiring pre-closing registration with provincial commerce bureaus.

Operational Impact for Universities, Joint Institutes, and Tech-Transfer Offices

The enforcement of interim registration imposes direct compliance obligations on international higher education institutions, Sino-foreign cooperative universities, and academic research centres. Academic administrators overseeing cross-border programmes must reconcile open research principles with tightening regulatory oversight. Institutional compliance leadership, particularly a university’s research security team, must establish structured screening mechanisms to ensure academic projects do not inadvertently violate export mandates.

Universities operating cooperative joint institutes in China face specific operational considerations. While open academic publishing remains exempt, collaborative laboratory work that involves sharing unpublished artificial intelligence model checkpoints, training datasets, or proprietary biological screening assays falls squarely within interim registration parameters. Research institutions handling advanced machine learning algorithms must review guidelines for export control and AI to prevent the unauthorized transfer of proprietary weights or specialized agent tools.

University technology-transfer offices (TTOs) and sponsored research offices must audit active licensing and collaboration agreements. Under Announcement [2026] No. 48, four operational triggers require immediate registration on the MOFCOM trade portal: outbound assignment of intellectual property ownership; licensing domestic proprietary technology for overseas utilization; corporate changes where the ownership or actual controller of domestic intellectual property shifts to a foreign entity; and specific administrative directives issued by commerce authorities.

When drafting cross-border research agreements, institutional negotiators must evaluate whether their transactional structure constitutes a collaborative development contract or a material transfer. Research administrators must examine the contractual differences between a research collaboration agreement and a material transfer agreement, ensuring that data-sharing provisions, biological sample transfers, and computational resource allocations do not promise the transfer of prohibited platform assets or unregistered restricted methodologies.

Implementation Milestones and Next Steps

With the public comment window concluded, Chinese authorities are consolidating feedback on the 40 proposed technology definitions, with formal promulgation of the revised Catalogue expected in early 2027. In the intervening period, the interim registration system remains fully enforceable across all provincial commerce departments.

Exporters, research institutes, and enterprise legal teams must submit registrations via the MOFCOM Unified Business Platform Technology Trade Management Information Application (`https://ecomp.mofcom.gov.cn`). Filings require detailed institutional data, identification of foreign recipients, end-use documentation, technical parameter descriptions, and projected transaction valuations. Transactions initiated prior to October 16, 2026, but not yet concluded, must complete retroactive registration prior to final closing.

Research administrators, technology-transfer officers, and multinational legal counsel should immediately implement a three-step compliance audit: catalog all active cross-border collaborative research projects touching artificial intelligence, photovoltaics, or biomanufacturing; screen project technical parameters against the 10²⁶ FLOPs and novel-target thresholds; and adjust contractual licensing provisions to safeguard foundational platform ownership within domestic legal jurisdictions.

Sources

Ask CASRAI · full access

Ask about this story

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →